Free Access to TSR Screeners - Sign Up for Your Nightly Pass
EBIT Analysis of Indoco Remedies - Deep Dive
Latest FY EBIT
Period Ending - Mar-25
-8.14 Cr
Period Ending - Mar-24
173.82 Cr
Growth
-104.68 %
Trailing Twelve Months EBIT
Period Ending - Mar-25
-3.91 Cr
Most recent Quarter EBIT
Period Ending - Mar-25
-26.59 Cr
Period Ending - Dec-24
-12.84 Cr
Growth
107.09 %
EBIT CAGR of INDOCO
3 Yr CAGR-26.67% | 5 Yr CAGR-16.11% | 7 Yr CAGR-11.07% | 10 Yr CAGR-7.54% |
EBIT Analysis of Indoco Remedies
EBIT of INDOCO drastically fell by -104.68 % this year. |
EBIT with value of 250.71 Cr was highest in Year Mar-22 in last Five Years. |
EBIT of INDOCO trending down for at least three Years. |
Latest EBIT with value of -8.14 Cr is lower than Average EBIT of 157.45 Cr in last five years. |
EBIT of INDOCO moved from Positive to Negative territory. |
Other EBIT Related Info of INDOCO that may interest you.
Indoco Remedies Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
INDOCO | 283.55 | 280.70 | 1.02 % | Drugs & Pharma |
Defination of EBIT
EBIT (earnings before interest and tax expenses ) is the profitability measurement that determines the company's profit before deducting interest expenses and tax expenses. more ..
EBIT Related Ratios
Revenue | NetIncome | OpsProfit | EBITDA | PAT | PBT |
Tsr Profitability Index
Poor Profitability Stock | Screener |
Key Financial Ratios on EBIT
Interest Coverage
-0.123
Debt To equity
0.972
FY - Historical EBIT of Indoco Remedies
Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
---|---|---|---|---|---|---|---|
EBIT | -8.14 Cr | 173.82 Cr | 217.83 Cr | 250.71 Cr | 153.04 Cr | 73.93 Cr | 40.32 Cr |
Change | -104.68 % | -20.20 % | -13.11 % | 63.82 % | 106.99 % | 83.37 % | -57.50 % |
Price | 232.89 | 328.65 | 325.25 | 377.05 | 287.55 | 210.40 | 202.30 |
Price Change | -29.14 % | 1.05 % | -13.74 % | 31.13 % | 36.67 % | 4.00 % | -4.64 % |
FY Chart of EBIT of Indoco Remedies
Quarterly Historical EBIT of Indoco Remedies
Period | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|---|---|---|
EBIT | -26.59 Cr | -12.84 Cr | 13.43 Cr | 22.09 Cr | 45.70 Cr | 33.44 Cr | 54.23 Cr |
Change | -107.09 % | -195.61 % | -39.20 % | -51.66 % | 36.66 % | -38.34 % | 29.40 % |